BioAtla, Inc.
BCAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $40,411 | $23,168 | $20,201 | $29,530 |
| - Cash | $8,320 | $18,207 | $32,363 | $49,046 |
| + Debt | $6,181 | $6,045 | $554 | $836 |
| Enterprise Value | $38,272 | $11,006 | -$11,608 | -$18,680 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$56 | -$567 | -$183 | -$11,650 |
| % Margin | – | – | – | – |
| EBITDA | -$15,722 | -$18,532 | -$17,431 | -$16,016 |
| % Margin | – | – | – | – |
| Net Income | -$15,778 | -$18,711 | -$15,334 | -$14,884 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.27 | -0.32 | -0.26 | -0.3 |
| % Growth | 15.6% | -23.1% | 13.3% | – |
| Operating Cash Flow | -$9,881 | -$14,198 | -$16,288 | -$16,783 |
| Capital Expenditures | $0 | $14,198 | $0 | $0 |
| Free Cash Flow | -$9,881 | $0 | -$16,288 | -$16,783 |